Details

Last Funding Type

Series Unknown

Last Funding Money Raised

$15M

Industries

Biotechnology,Health Care,Medical

Founded date

Jan 1, 1998

Number Of Employee

11 - 50

Operating Status

Active

IatroQuest Corporation's breakthrough, patent-pending biosensing platform technology called Bio-Alloy™, is made possible by the convergence of nanotechnology, advanced semi-conductor materials, biotechnology and photonics. This Bio-Alloy platform will allow a wide range of product lines covering many market segments: from Biosensing Cartridges for the biodefense industry and high-density microarrays for drug discovery applications to Point-of-Care diagnostics and environmental monitoring. The unique attributes of Bio-Alloy™ enable it to detect and identify in real-time a wide range of biological agents, as well as specific small chemical molecules, with a high degree of sensitivity and selectivity.